{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:44:38Z","timestamp":1792788278001,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["62076015"],"award-info":[{"award-number":["62076015"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"REaDI Fund of Massey University","id":[{"id":"https:\/\/ror.org\/052czxv31","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["L252088"],"award-info":[{"award-number":["L252088"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"DOI":"10.1186\/s13058-026-02342-4","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T10:44:38Z","timestamp":1783680278000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and validation of an immune-related molecular subtyping model based on a four-gene prognostic biomarker signature and multi-omics integrative analysis in Luminal B breast cancer"],"prefix":"10.1186","volume":"28","author":[{"given":"Junqi","family":"Long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiashuai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gege","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yining","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangtao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"issue":"1","key":"2342_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"Cancer J Clin"},{"issue":"2","key":"2342_CR2","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s12282-023-01523-9","volume":"31","author":"Z Tang","year":"2024","unstructured":"Tang Z, Li L, Huang X, Zhao Y, Huang L. Association of molecular subtypes and treatment with survival in invasive micropapillary breast cancer: an analysis of the Surveillance, Epidemiology, and End Results database. Breast Cancer. 2024;31(2):205\u201316.","journal-title":"Breast Cancer"},{"issue":"25","key":"2342_CR3","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1200\/JCO.2012.46.1574","volume":"31","author":"O Metzger-Filho","year":"2013","unstructured":"Metzger-Filho O, Sun Z, Viale G, Price KN, Crivellari D, Snyder RD, et al. Patterns of recurrence and outcome according to breast cancer subtypes in lymph node\u2013negative disease: results from international breast cancer study group trials VIII and IX. J Clin Oncol. 2013;31(25):3083\u201390.","journal-title":"J Clin Oncol"},{"key":"2342_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.heliyon.2024.e38493","volume":"10","author":"A Ismail","year":"2024","unstructured":"Ismail A, Panjwani S, Ismail N, Ngimba C, Mosha I, Adebayo P, et al. Breast cancer molecular subtype classification according to immunohistochemistry markers and its association with pathological characteristics among women attending tertiary hospitals in Tanzania. Heliyon. 2024;10:19.","journal-title":"Heliyon"},{"issue":"9","key":"2342_CR5","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1093\/annonc\/mdt183","volume":"24","author":"I Castellano","year":"2013","unstructured":"Castellano I, Chiusa L, Vandone AM, Beatrice S, Goia M, Donadio M, et al. A simple and reproducible prognostic index in luminal ER-positive breast cancers. Ann Oncol. 2013;24(9):2292\u20137.","journal-title":"Ann Oncol"},{"issue":"5","key":"2342_CR6","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.clbc.2012.07.001","volume":"12","author":"E Munzone","year":"2012","unstructured":"Munzone E, Botteri E, Sandri MT, Esposito A, Adamoli L, Zorzino L, et al. Prognostic value of circulating tumor cells according to immunohistochemically defined molecular subtypes in advanced breast cancer. Clin Breast Cancer. 2012;12(5):340\u20136.","journal-title":"Clin Breast Cancer"},{"issue":"25","key":"2342_CR7","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1200\/JCO.2013.54.1870","volume":"32","author":"F Ades","year":"2014","unstructured":"Ades F, Zardavas D, Bozovic-Spasojevic I, Pugliano L, Fumagalli D, de Azambuja E, et al. Luminal B breast cancer: molecular characterization, clinical management, and future perspectives. J Clin Oncol. 2014;32(25):2794\u2013803.","journal-title":"J Clin Oncol"},{"key":"2342_CR8","doi-asserted-by":"crossref","unstructured":"Camargo-Herrera V, Castellanos G, Rangel N, Jim\u00e9nez-Tob\u00f3n GA, Mart\u00ednez-Ag\u00fcero M, Rond\u00f3n-Lagos M. Patterns of chromosomal instability and clonal heterogeneity in luminal B breast cancer: a pilot study. Int J Mol Sci. 2024;25(8):4478.","DOI":"10.3390\/ijms25084478"},{"key":"2342_CR9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/978-3-319-67577-0_4","volume":"1036","author":"T Frankel","year":"2017","unstructured":"Frankel T, Lanfranca MP, Zou W. The role of tumor microenvironment in cancer immunotherapy. Adv Exp Med Biol. 2017;1036:51\u201364.","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"2342_CR10","doi-asserted-by":"publisher","first-page":"3584","DOI":"10.1038\/s41467-020-17414-y","volume":"11","author":"M Terranova-Barberio","year":"2020","unstructured":"Terranova-Barberio M, Pawlowska N, Dhawan M, Moasser M, Chien AJ, Melisko ME, et al. Exhausted T cell signature predicts immunotherapy response in ER-positive breast cancer. Nat Commun. 2020;11(1):3584.","journal-title":"Nat Commun"},{"key":"2342_CR11","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.breast.2016.07.015","volume":"29","author":"S Luen","year":"2016","unstructured":"Luen S, Virassamy B, Savas P, Salgado R, Loi S. The genomic landscape of breast cancer and its interaction with host immunity. Breast. 2016;29:241\u201350.","journal-title":"Breast"},{"issue":"2","key":"2342_CR12","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s10549-020-05771-7","volume":"183","author":"C Criscitiello","year":"2020","unstructured":"Criscitiello C, Vingiani A, Maisonneuve P, Viale G, Viale G, Curigliano G. Tumor-infiltrating lymphocytes (TILs) in ER+\/HER2- breast cancer. Breast Cancer Res Treat. 2020;183(2):347\u201354.","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"2342_CR13","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1093\/jnci\/djz213","volume":"112","author":"M Anurag","year":"2020","unstructured":"Anurag M, Zhu M, Huang C, Vasaikar S, Wang J, Hoog J, et al. Immune checkpoint profiles in luminal B breast cancer (alliance). J Natl Cancer Inst. 2020;112(7):737\u201346.","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"2342_CR14","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1002\/cam4.5089","volume":"12","author":"ZJ Yang","year":"2023","unstructured":"Yang ZJ, Liu YX, Huang Y, Chen ZJ, Zhang HZ, Yu Y, et al. The regrouping of Luminal B (HER2 negative), a better discriminator of outcome and recurrence score. Cancer Med. 2023;12(3):2493\u2013504.","journal-title":"Cancer Med"},{"issue":"6","key":"2342_CR15","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/s41591-019-0432-4","volume":"25","author":"L Voorwerk","year":"2019","unstructured":"Voorwerk L, Slagter M, Horlings HM, Sikorska K, van de Vijver KK, de Maaker M, et al. Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial. Nat Med. 2019;25(6):920\u20138.","journal-title":"Nat Med"},{"issue":"9","key":"2342_CR16","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1038\/nm1622","volume":"13","author":"L Apetoh","year":"2007","unstructured":"Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A, et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med. 2007;13(9):1050\u20139.","journal-title":"Nat Med"},{"issue":"2","key":"2342_CR17","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1158\/1078-0432.CCR-21-2260","volume":"28","author":"MV Dieci","year":"2022","unstructured":"Dieci MV, Guarneri V, Tosi A, Bisagni G, Musolino A, Spazzapan S, et al. Neoadjuvant chemotherapy and immunotherapy in luminal B-like breast cancer: results of the phase II GIADA trial. Clin Cancer Res. 2022;28(2):308\u201317.","journal-title":"Clin Cancer Res"},{"key":"2342_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ctrv.2016.03.011","volume":"46","author":"MV Dieci","year":"2016","unstructured":"Dieci MV, Griguolo G, Miglietta F, Guarneri V. The immune system and hormone-receptor positive breast cancer: Is it really a dead end? Cancer Treat Rev. 2016;46:9\u201319.","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"2342_CR19","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1158\/1078-0432.CCR-08-1507","volume":"15","author":"D Generali","year":"2009","unstructured":"Generali D, Bates G, Berruti A, Brizzi MP, Campo L, Bonardi S, et al. Immunomodulation of FOXP3\u2009+\u2009regulatory T cells by the aromatase inhibitor letrozole in breast cancer patients. Clin Cancer Res. 2009;15(3):1046\u201351.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"2342_CR20","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41568-024-00694-7","volume":"24","author":"R Perez-Lopez","year":"2024","unstructured":"Perez-Lopez R, Ghaffari Laleh N, Mahmood F, Kather JN. A guide to artificial intelligence for cancer researchers. Nat Rev Cancer. 2024;24(6):427\u201341.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"2342_CR21","first-page":"041007","volume":"2","author":"W Guo","year":"2015","unstructured":"Guo W, Li H, Zhu Y, Lan L, Yang S, Drukker K, et al. Prediction of clinical phenotypes in invasive breast carcinomas from the integration of radiomics and genomics data. J Med Imaging (Bellingham). 2015;2(4):041007.","journal-title":"J Med Imaging (Bellingham)"},{"issue":"10","key":"2342_CR22","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/s41588-023-01507-7","volume":"55","author":"X Jin","year":"2023","unstructured":"Jin X, Zhou Y-F, Ma D, Zhao S, Lin C-J, Xiao Y, et al. Molecular classification of hormone receptor-positive HER2-negative breast cancer. Nat Genet. 2023;55(10):1696\u2013708.","journal-title":"Nat Genet"},{"key":"2342_CR23","doi-asserted-by":"crossref","unstructured":"Wang H, Liu B, Long J, Yu J, Ji X, Li J et al. Integrative analysis identifies two molecular and clinical subsets in Luminal B breast cancer. Iscience. 2023;26(9):107466 .","DOI":"10.1016\/j.isci.2023.107466"},{"key":"2342_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:1\u201321.","journal-title":"Genome Biol"},{"key":"2342_CR25","unstructured":"Meyer D, Dimitriadou E, Hornik K, Weingessel A, Leisch F, Chang C-C et al. e1071: misc functions of the department of statistics, probability theory group (formerly: E1071), TU Wien. R package version. 2019;1(2)."},{"key":"2342_CR26","unstructured":"Hothorn T, Hornik K, Strobl C, Zeileis A, Hothorn MT. Package \u2018party\u2019. Package reference manual for party version 09-998. 2015;16:37."},{"key":"2342_CR27","unstructured":"Kuhn M, Wing J, Weston S, Williams A, Keefer C, Engelhardt A et al. Package \u2018caret\u2019. R J. 2020;223(7):48."},{"key":"2342_CR28","first-page":"113","volume":"538","author":"B Ripley","year":"2013","unstructured":"Ripley B, Venables B, Bates DM, Hornik K, Gebhardt A, Firth D, et al. Package \u2018mass\u2019. Cran r. 2013;538:113\u201320.","journal-title":"Cran r"},{"key":"2342_CR29","unstructured":"Therneau T, Atkinson B, Ripley B, Ripley MB. April. Package \u2018rpart\u2019. 2015. Available online: cran ma ic ac uk \/web\/packages\/rpart\/rpart pdf. Accessed on 20 2016"},{"key":"2342_CR30","unstructured":"Kuhn M, Weston S, Culp M, Coulter N, Quinlan R. Package \u2018C50\u2019. CRAN, UTC. 2015."},{"key":"2342_CR31","unstructured":"RColorBrewer S, Liaw MA. Package \u2018randomforest\u2019. University of California, Berkeley: Berkeley, CA, USA. 2018."},{"issue":"10","key":"2342_CR32","first-page":"28","volume":"128","author":"TM Therneau","year":"2015","unstructured":"Therneau TM, Lumley T. Package \u2018survival\u2019. R Top Doc. 2015;128(10):28\u201333.","journal-title":"R Top Doc"},{"key":"2342_CR33","unstructured":"Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez J-C et al. Package \u2018pROC\u2019. Package pROC. 2021."},{"key":"2342_CR34","doi-asserted-by":"crossref","unstructured":"Harrell J, Frank E, Harrell FE. Cox proportional hazards regression model. Regression modeling strategies: With applications to linear models, logistic and ordinal regression, and survival analysis. 2015:475\u2013519.","DOI":"10.1007\/978-3-319-19425-7_20"},{"key":"2342_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/gb-2011-12-4-r41","volume":"12","author":"CH Mermel","year":"2011","unstructured":"Mermel CH, Schumacher SE, Hill B, Meyerson ML, Beroukhim R, Getz G. GISTIC2. 0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 2011;12:1\u201314.","journal-title":"Genome Biol"},{"issue":"3","key":"2342_CR36","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1002\/imt2.43","volume":"1","author":"Z Gu","year":"2022","unstructured":"Gu Z. Complex heatmap visualization. Imeta. 2022;1(3):e43.","journal-title":"Imeta"},{"issue":"24","key":"2342_CR37","doi-asserted-by":"publisher","first-page":"3982","DOI":"10.1093\/bioinformatics\/btx513","volume":"33","author":"Y Tian","year":"2017","unstructured":"Tian Y, Morris TJ, Webster AP, Yang Z, Beck S, Feber A, et al. ChAMP: updated methylation analysis pipeline for Illumina BeadChips. Bioinformatics. 2017;33(24):3982\u20134.","journal-title":"Bioinformatics"},{"issue":"7","key":"2342_CR38","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47\u2013e.","journal-title":"Nucleic Acids Res"},{"issue":"13Supplement","key":"2342_CR39","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1158\/1538-7445.AM2018-923","volume":"78","author":"J Gao","year":"2018","unstructured":"Gao J, Mazor T, Ciftci E, Raman P, Lukasse P, Bahceci I, et al. The cbioportal for cancer genomics: an intuitive open-source platform for exploration, analysis and visualization of cancer genomics data. Cancer Res. 2018;78(13Supplement):923.","journal-title":"Cancer Res"},{"issue":"6","key":"2342_CR40","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsd\u00f3ttir H, Ghandi M, Mesirov JP, Tamayo P. The molecular signatures database hallmark gene set collection. Cell Syst. 2015;1(6):417\u201325.","journal-title":"Cell Syst"},{"key":"2342_CR41","doi-asserted-by":"crossref","unstructured":"Ginestet C. ggplot2: elegant graphics for data analysis. Oxford University Press; 2011.","DOI":"10.1111\/j.1467-985X.2010.00676_9.x"},{"key":"2342_CR42","doi-asserted-by":"crossref","unstructured":"Korotkevich G, Sukhov V, Budin N, Shpak B, Artyomov MN, Sergushichev A. Fast gene set enrichment analysis. BioRxiv. 2016:060012.","DOI":"10.1101\/060012"},{"issue":"D1","key":"2342_CR43","doi-asserted-by":"publisher","first-page":"D92","DOI":"10.1093\/nar\/gkt1248","volume":"42","author":"J-H Li","year":"2014","unstructured":"Li J-H, Liu S, Zhou H, Qu L-H, Yang J-H. starBase v2. 0: decoding miRNA-ceRNA, miRNA-ncRNA and protein\u2013RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42(D1):D92\u20137.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"2342_CR44","doi-asserted-by":"publisher","first-page":"D140","DOI":"10.1093\/nar\/gky1051","volume":"47","author":"L Cheng","year":"2019","unstructured":"Cheng L, Wang P, Tian R, Wang S, Guo Q, Luo M, et al. LncRNA2Target v2.0: a comprehensive database for target genes of lncRNAs in human and mouse. Nucleic Acids Res. 2019;47(D1):D140\u20134.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"2342_CR45","first-page":"D118","volume":"48","author":"H Zhao","year":"2020","unstructured":"Zhao H, Shi J, Zhang Y, Xie A, Yu L, Zhang C, et al. LncTarD: a manually-curated database of experimentally-supported functional lncRNA-target regulations in human diseases. Nucleic Acids Res. 2020;48(D1):D118\u201326.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"2342_CR46","doi-asserted-by":"publisher","first-page":"D231","DOI":"10.1093\/nar\/gkv1270","volume":"44","author":"MD Paraskevopoulou","year":"2016","unstructured":"Paraskevopoulou MD, Vlachos IS, Karagkouni D, Georgakilas G, Kanellos I, Vergoulis T, et al. DIANA-LncBase v2: indexing microRNA targets on non-coding transcripts. Nucleic Acids Res. 2016;44(D1):D231\u20138.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"2342_CR47","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498\u2013504.","journal-title":"Genome Res"},{"issue":"1","key":"2342_CR48","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1186\/s12885-024-12182-0","volume":"24","author":"C Qiu","year":"2024","unstructured":"Qiu C, Wang W, Xu S, Li Y, Zhu J, Zhang Y, et al. Construction and validation of a hypoxia-related gene signature to predict the prognosis of breast cancer. BMC Cancer. 2024;24(1):402.","journal-title":"BMC Cancer"},{"issue":"2","key":"2342_CR49","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00432-024-05612-w","volume":"150","author":"X Chen","year":"2024","unstructured":"Chen X, Tang P, Kong Y, Chen D, Tang K. Identification and validation of Golgi apparatus-related signature for predicting prognosis and immunotherapy response in breast cancer. J Cancer Res Clin Oncol. 2024;150(2):61.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"2342_CR50","doi-asserted-by":"publisher","first-page":"428","DOI":"10.7150\/jca.90113","volume":"15","author":"T Yu","year":"2024","unstructured":"Yu T, Cheng W, Zhang J, Wang T, Liu Y, Duan Y, et al. Identification of a PANoptosis-related gene signature for predicting the prognosis, tumor microenvironment and therapy response in breast cancer. J Cancer. 2024;15(2):428.","journal-title":"J Cancer"},{"key":"2342_CR51","doi-asserted-by":"crossref","unstructured":"Liu X, Sun K, Yang H, Zou D, Xia L, Lu K et al. Molecular subtype identification and prognosis stratification based on lysosome-related genes in breast cancer. Heliyon. 2024;10(4).","DOI":"10.1016\/j.heliyon.2024.e25643"},{"issue":"2","key":"2342_CR52","doi-asserted-by":"publisher","first-page":"649","DOI":"10.18632\/aging.101767","volume":"11","author":"J Lai","year":"2019","unstructured":"Lai J, Wang H, Pan Z, Su F. A novel six-microRNA-based model to improve prognosis prediction of breast cancer. Aging. 2019;11(2):649.","journal-title":"Aging"},{"issue":"1","key":"2342_CR53","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1038\/s41598-024-52981-w","volume":"14","author":"Y Wang","year":"2024","unstructured":"Wang Y, Wang D-y, Bu K-n, Gao J-d. Zhang B-l. Prognosis prediction and risk stratification of breast cancer patients based on a mitochondria-related gene signature. Sci Rep. 2024;14(1):2859.","journal-title":"Sci Rep"},{"issue":"3","key":"2342_CR54","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/S0002-9440(10)63362-7","volume":"165","author":"SV Ivanov","year":"2004","unstructured":"Ivanov SV, Ward JM, Tessarollo L, McAreavey D, Sachdev V, Fananapazir L, et al. Cerebellar ataxia, seizures, premature death, and cardiac abnormalities in mice with targeted disruption of the Cacna2d2 gene. Am J Pathol. 2004;165(3):1007\u201318.","journal-title":"Am J Pathol"},{"issue":"53","key":"2342_CR55","doi-asserted-by":"publisher","first-page":"91379","DOI":"10.18632\/oncotarget.20557","volume":"8","author":"J Wang","year":"2017","unstructured":"Wang J, Ye C, Lu D, Chen Y, Jia Y, Ying X, et al. Matrix metalloproteinase-1 expression in breast carcinoma: a marker for unfavorable prognosis. Oncotarget. 2017;8(53):91379.","journal-title":"Oncotarget"},{"issue":"2","key":"2342_CR56","doi-asserted-by":"publisher","first-page":"e3001090","DOI":"10.1371\/journal.pbio.3001090","volume":"19","author":"M He","year":"2021","unstructured":"He M, Zhou T, Niu Y, Feng W, Gu X, Xu W, et al. The protease corin regulates electrolyte homeostasis in eccrine sweat glands. PLoS Biol. 2021;19(2):e3001090.","journal-title":"PLoS Biol"},{"key":"2342_CR57","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10549-021-06133-7","volume":"187","author":"AW Ware","year":"2021","unstructured":"Ware AW, Harris JJ, Slatter TL, Cunliffe HE, McDonald FJ. The epithelial sodium channel has a role in breast cancer cell proliferation. Breast Cancer Res Treat. 2021;187:31\u201343.","journal-title":"Breast Cancer Res Treat"},{"key":"2342_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-015-0154-5","volume":"34","author":"J Liu","year":"2015","unstructured":"Liu J, Xue H, Zhang J, Suo T, Xiang Y, Zhang W, et al. MicroRNA-144 inhibits the metastasis of gastric cancer by targeting MET expression. J Experimental Clin Cancer Res. 2015;34:1\u20139.","journal-title":"J Experimental Clin Cancer Res"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-026-02342-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02342-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02342-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:03:23Z","timestamp":1791216203000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13058-026-02342-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2342"],"URL":"https:\/\/doi.org\/10.1186\/s13058-026-02342-4","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"9 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This research complied with the Declaration of Helsinki. Most datasets used in this study are publicly available, with anonymization performed by the data providers. Similarly, private datasets were also anonymized, and their collection and use were reviewed and approved by the Institutional Review Committee.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not required.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"170"}}